Suzanne Oparil MD

Professor, Medicine, University of Alabama School of Medicine

1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Fax+1 205-934-1302

Dr. Oparil is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Oparil's full profile Already have an account?

Summary

Director, Vascular Biology & Hypertension Program

Education & Training

Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1969 - 1970
Boston University Medical CenterResidency, Internal Medicine, 1968 - 1969
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1967 - 1968
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1965 - 1967
Columbia University Vagelos College of Physicians and SurgeonsClass of 1965

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 1971 - Present
AL State Medical License 1977 - 2023

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MyHealth@UABMedicine, UAB Health System, 2013-2014, 2016-2017
CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2013-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2013-2014, 2016-2017

Clinical Trials

The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy Start of enrollment: 2008 Mar 01
Completed
Phase 4
Systolic Blood Pressure Intervention Trial Start of enrollment: 2010 Oct 01
Completed
Not Applicable
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT Start of enrollment: 2013 Jun 01
Completed
Not Applicable

Publications & Presentations

PubMed

Validation of a Remote Monitoring Blood Pressure Device in a General Population Cohort.
Matthew M Moore, Ayamo Oben, Paul Muntner, Stacy Harris, Nancy Saxon
American Journal of Hypertension. 2026-06-19
Centering Community Engagement in a Hypertension Clinical Trial: Strategies to Engage Rural Black Patients in the Southeastern Collaboration to Improve Blood Pressure ...
Stephanie Hart, Doyle M Cummings, Monika M Safford, Andrea L Cherrington, Jacqueline R Halladay
Journal of Racial and Ethnic Health Disparities. 2025-12-20
6 citations
Blood pressure control in pregnant patients with chronic hypertension and diabetes: should <130/80 be the target?
Lorie M Harper, Hui-Chien Kuo, Kim Boggess, Lorraine Dugoff, Baha Sibai
American Journal of Obstetrics and Gynecology. 2025-05-01

Journal Articles

Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice
Suzanne Oparil, Mark A Parkulo, Priscilla Pemu, Paul K Whelton, JAMA Internal Medicine
Chlorthalidone and Hydrochlorothiazide for Treatment of Patients with Hypertension
Franz H Messerli, George C Roush, Suzanne Oparil, JAMA Internal Medicine
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
Udayan Y Bhatt, Clinton B Wright, Vasilios Papademetriou, Joachim H Ix, Michael G Shlipak, Alfred K Cheung, Mark J Sarnak, Jing Chen, Charles Ginsberg, Glenn M Chertow..., Journal of the American Society of Nephrology

Lectures

Hypertension Treatment in the Era of Precision Medicine
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

Chlorthalidone and Hydrochlorothiazide for Treatment of Patients with HypertensionJune 2020

Press Mentions

David Sibley, MD Began His Career with a Diagnostic BreakthroughFebruary 21st, 2023
Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISIONNovember 9th, 2022
AHA 2022 – Idorsia and Cincor move forward in hypertensionNovember 8th, 2022

Grant Support

Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)UNIVERSITY OF ALABAMA AT BIRMINGHAM2014–2026